Neuland Laboratories · NSE: NEULANDLAB · BSE: 524558
Q3 FY23 results · Oct–Dec 2022
Neuland Laboratories reported revenue from operations of ₹269.25 crore (up 13.9% from Q3 FY22) and net profit of ₹30.55 crore (up 136.2% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 269.25 | 236.47 | +13.9% | 293.71 | −8.3% |
| Other income | 0.93 | 1.90 | −50.9% | 0.24 | +290.3% |
| Total income | 270.18 | 238.37 | +13.3% | 293.94 | −8.1% |
| Profit before tax | 38.94 | 18.24 | +113.5% | 53.19 | −26.8% |
| Net profit for the period | 30.55 | 12.94 | +136.2% | 38.46 | −20.6% |
| EPS, basic (₹) | 23.81 | 10.08 | +136.2% | 29.97 | −20.6% |
| Net margin (%) | 11.3 | 5.5 | 13.1 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 269.25 | 236.47 | +13.9% | 293.71 | −8.3% |
| Other income | 0.93 | 1.90 | −50.9% | 0.24 | +290.3% |
| Total income | 270.18 | 238.37 | +13.3% | 293.94 | −8.1% |
| Profit before tax | 38.80 | 18.10 | +114.4% | 53.06 | −26.9% |
| Net profit for the period | 30.44 | 12.73 | +139.0% | 38.33 | −20.6% |
| EPS, basic (₹) | 23.72 | 9.92 | +139.0% | 29.88 | −20.6% |
| Net margin (%) | 11.3 | 5.4 | 13.1 |
Consolidated
- Filed with BSE
- 16 Feb 2023, 16:12 IST
- Board meeting
- 13 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 16 Feb 2023, 16:12 IST
- Board meeting
- 13 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE